132 related articles for article (PubMed ID: 2347734)
1. Radiobiological aspects of low dose rates in radioimmunotherapy.
Fowler JF
Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1261-9. PubMed ID: 2347734
[TBL] [Abstract][Full Text] [Related]
2. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
3. How worthwhile are short schedules in radiotherapy? A series of exploratory calculations.
Fowler JF
Radiother Oncol; 1990 Jun; 18(2):165-81. PubMed ID: 2367691
[TBL] [Abstract][Full Text] [Related]
4. [The dosage-performance effects on Ca-Ski and HPK cells in relation to the dose and fractionation].
Schulz-Wendtland R; Krämer S; Keilholz L; Pflüger S; Lang N
Strahlenther Onkol; 1996 Aug; 172(8):439-45. PubMed ID: 8765347
[TBL] [Abstract][Full Text] [Related]
5. The dose-rate effect revisited: radiobiological considerations of importance in radiotherapy.
Hall EJ; Brenner DJ
Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1403-14. PubMed ID: 1938548
[TBL] [Abstract][Full Text] [Related]
6. The effects of altered fractionation schedules on the survival of human cell lines differing in their proliferative activity and repair capacity.
Konefal JB; Taylor YC
Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):1007-13. PubMed ID: 2808033
[TBL] [Abstract][Full Text] [Related]
7. Radiobiology of radiolabeled antibody therapy as applied to tumor dosimetry.
Langmuir VK; Fowler JF; Knox SJ; Wessels BW; Sutherland RM; Wong JY
Med Phys; 1993; 20(2 Pt 2):601-10. PubMed ID: 8492769
[TBL] [Abstract][Full Text] [Related]
8. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone.
Gasinska A; Fowler JF; Lind BK; Urbanski K
Acta Oncol; 2004; 43(7):657-66. PubMed ID: 15545186
[TBL] [Abstract][Full Text] [Related]
9. A rationale for fractionation for slowly proliferating tumors such as prostatic adenocarcinoma.
Fowler JF; Ritter MA
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):521-9. PubMed ID: 7751194
[TBL] [Abstract][Full Text] [Related]
10. [Effects of fractionation and dose rate in PDR brachytherapy of B14 cells].
Keilholz L; Seegenschmiedt MH; Lotter M; Schulz-Wendtland R; von Erffa J; Pflüger S; Sauer R
Strahlenther Onkol; 1998 Feb; 174(2):64-70. PubMed ID: 9487367
[TBL] [Abstract][Full Text] [Related]
11. Loss of radiobiological effect of imaging dose in image guided radiotherapy due to prolonged imaging-to-treatment times.
Flynn RT
Med Phys; 2010 Jun; 37(6):2761-9. PubMed ID: 20632586
[TBL] [Abstract][Full Text] [Related]
12. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
Dicker AP; Lin CC; Leeper DB; Waterman FM
Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
[TBL] [Abstract][Full Text] [Related]
13. Solid tumor models for the assessment of different treatment modalities: XXVI. Estimates of cell survival from tumor growth delay after alternating radiotherapy and chemotherapy.
Hopkins HA; Looney WB
Int J Radiat Oncol Biol Phys; 1987 Feb; 13(2):217-24. PubMed ID: 3818388
[TBL] [Abstract][Full Text] [Related]
14. A challenge to traditional radiation oncology.
Fowler JF; Tomé WA; Fenwick JD; Mehta MP
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1241-56. PubMed ID: 15519797
[TBL] [Abstract][Full Text] [Related]
15. Predicting realistic RBE values for clinically relevant radiotherapy schedules.
Denekamp J; Waites T; Fowler JF
Int J Radiat Biol; 1997 Jun; 71(6):681-94. PubMed ID: 9246183
[TBL] [Abstract][Full Text] [Related]
16. Comparison of systemic radiotherapy with I-131-labeled monoclonal antibody BW575/9 to external beam radiotherapy in human neuroblastoma xenografts.
Sautter-Bihl ML; Wessely R; Bihl H
Strahlenther Onkol; 1993 Oct; 169(10):595-600. PubMed ID: 8235984
[TBL] [Abstract][Full Text] [Related]
17. The relative biological effectiveness of ytterbium-169 for low dose rate irradiation of cultured mammalian cells.
Plume CA; Daly SE; Porter AT; Barnett RB; Battista JJ
Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):835-40. PubMed ID: 8478234
[TBL] [Abstract][Full Text] [Related]
18. Response of glioblastoma cell lines to low dose rate irradiation.
Marin LA; Smith CE; Langston MY; Quashie D; Dillehay LE
Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):397-402. PubMed ID: 2061116
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
Pop LA; Millar WT; Visser AG; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
[TBL] [Abstract][Full Text] [Related]
20. Influence of dose-rate and dose per fraction on clinical outcome of breast cancer treated by external beam irradiation plus iridium-192 implants: analysis of 289 cases.
Deore SM; Sarin R; Dinshaw KA; Shrivastava SK
Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):601-6. PubMed ID: 8330988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
